Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Smoking molecular damage in bronchial epithelium.

Ignacio I Wistuba1, Li Mao, Adi F Gazdar

  • 1Department of Anatomic Pathology, Pontificia Universidad Catolica de Chile, Santiago, P.O. Box 114-D, Chile.

Oncogene
|October 16, 2002
PubMed
Summary

Lung cancer development involves multiple gene mutations. Molecular abnormalities in bronchial epithelium may offer early diagnostic and risk assessment biomarkers for lung cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editor's Note: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR.

Cancer research·2025
Same author

Development of Human Adrenocortical Adenoma (HAA1) Cell Line from Zona Reticularis.

International journal of molecular sciences·2023
Same author

A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneity.

Nature cancer·2022
Same author

SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas.

Journal of the National Cancer Institute·2021
Same author

SCT Promoter Methylation is a Highly Discriminative Biomarker for Lung and Many Other Cancers.

IEEE life sciences letters·2021
Same author

Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer.

Communications biology·2021

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Lung cancer pathogenesis is increasingly understood through molecular alterations.
  • Malignant phenotypes require numerous oncogene mutations (dominant and recessive).
  • Genetic and epigenetic changes are observed across lung cancer types, with some being cell-specific.

Purpose of the Study:

  • To elucidate the specific roles of mutated genes in lung cancer.
  • To determine the sequence of molecular changes leading to different lung cancer types.
  • To explore the potential of molecular abnormalities as biomarkers.

Main Methods:

  • Analysis of genetic and epigenetic alterations in lung cancer tissues.
  • Investigation of molecular changes in preneoplastic bronchial epithelium.
  • Correlation of molecular findings with lung cancer histology and smoking status.

Main Results:

  • Identification of specific genes and chromosomal regions associated with lung cancer.
  • Observation of common and cell-type-specific molecular changes.
  • Detection of molecular abnormalities in normal-appearing and preneoplastic tissues.

Conclusions:

  • Lung cancer arises from cumulative genetic and epigenetic events.
  • Molecular changes in bronchial epithelium could serve as early diagnostic biomarkers.
  • These biomarkers may aid in risk assessment and monitoring chemoprevention efficacy.

Related Experiment Videos